Bobotik drops vn.pr. 66.66mg / ml-30ml vial cap.

Description

Composition
Active substance:
1 ml contains: Simethicone – 66.66 mg / ml (30% in the form of an emulsion – 222.2 mg / ml).
Excipients:
Sodium saccharin, methyl parahydroxybenzoate, propyl parahydroxybenzoate, sodium carmellose, citric acid monohydrate, raspberry flavor, purified water.
Description:
Dense, opaque liquid from white to white with cream tint color with a fruity odor.
Allowed separation into a liquid layer and precipitate which, after stirring to form a homogeneous emulsion.
Product form:
Drops for oral, 66.66 mg / ml.
30 ml amber glass vials with a polyethylene dropper and a cork-screw-cap polyethylene. 1 vial together with instructions for use in a cardboard package.
Contraindications
Hypersensitivity to simethicone and / or other components of the formulation; bowel obstruction; obstructive diseases of the gastrointestinal tract; newborns up to 28 days of life.
Dosage
66.66 mg / ml
Indications
Increased gas formation and accumulation of gases in the gastrointestinal tract (cramps, feeling of fullness in the abdomen, including flatulence postoperative Remgelda syndrome, aerophagia); preparation for a diagnostic test of abdominal cavity and the pelvic (radiography, sonography, gastroscopy and duodenoscopy – foam prevention).
Interaction with other drugs
Simethicone can cause malabsorption of oral anticoagulants.
Overdose
Reports of overdose are not available.
Simethicone is not absorbed from the gastrointestinal tract, and an overdose is not a threat to life and health.
pharmachologic effect
Pharmacological group:
Carminative.
Pharmacodynamics:
Simethicone (activated dimethicone) is a combination of methylated linear siloxane polymers stabilized trimetilsiloksilovymi groups of silica. By reducing the surface tension on the phase boundary, it hinders the formation and contributes to the destruction of the gas bubbles in the contents of the intestinal mucus and gastrointestinal tract (GIT). Released when the gases can be absorbed by the intestinal walls or output through peristalsis. This prevents the formation of large gas-mucous conglomerates, causing painful bloating.
When sono- radiography and prevents the occurrence of image defects; It promotes better irrigation colonic mucosa contrasting agents, preventing rupture contrast film.
Due to the chemical inertness does not affect the microorganisms and enzymes present in the gastrointestinal tract. Does not reduce food intake, does not change the response and volume of gastric juice.
Pharmacokinetics:
Simethicone after oral administration is not absorbed from the digestive tract through the intestines and excreted unaltered.
Pregnancy and breast-feeding
During pregnancy, the use of the drug is possible only in those cases where the intended benefits to the mother outweighs the potential risk to the fetus.
There are no data on the safety of the drug in lactating women. During feeding her child the drug should be used only in case of absolute necessity.
Conditions of supply of pharmacies
Without recipe.
side effects
May develop allergic reactions.
special instructions
The drug does not contain sugar, may use diabetics and digestive disturbances.
During treatment is not recommended intake of carbonated drinks.
The drug may distort the results of some diagnostic tests, such as test using guaiac.
Driving and operating maintenance of mechanical devices
The drug has no effect on driving vehicles and maintenance of mechanical devices.
Storage conditions
In the dark place at a temperature of from 15 C to 25 C.
Keep out of the reach of children.
Dosing and Administration
Inside, after a meal.
Shake before use to obtain a homogeneous emulsion.
For accurate dosage of the drug, during instillation, the vial should be held vertically.
Reinforced gas formation and accumulation of gas in the gastrointestinal tract: the children from the 28 days of life up to 2 years to 8 drops (20 mg simethicone) 4 times a day; children from 2 to 6 years to 14 drops (35 mg simethicone) 4 times a day; Children older than 6 years and adults 16 drops (40 mg simethicone) 4 times a day.
For easier administration, particularly small children, it may be pre-mixed with a small amount of cold boiled water, baby food or non-carbonated liquid.
After the disappearance of the symptoms of the drug should be discontinued.
Preparations for diagnostic procedures:
Gastrointestinal radiographic study
One day prior to study drug taking 2 times a day (morning and evening): children from 28 days of life up to 2 years – 10 drops (25 mg) Children from 2 to 6 years – 16 drops (40 mg) of children aged 6 years and adult – 20 drops (50 mg)
Sonographic study of the gastrointestinal tract
One day prior to study drug taking 2 times a day (morning and evening) in the dosages recommended in preparation for X-ray studies. Three hours before the start of the study the dose should be repeated.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist